Unrealized potential of drug repositioning in Europe during COVID-19 and beyond: a physician’s perspective

Figures & data

Table 1 Summary of the three application procedures in the European Union

Fig. 1 Algorithm for drug repositioning pathways in the European Union

Table 2 Price development of chenodeoxycholic acid from 2008 to 2017 [29]

Table 3 List of drugs that are currently being clinically investigated as potential repositioned treatment for COVID-19 [51]

Daniel MG, Pawlik TM, Fader AN, Esnaola NF, Makary MA. The orphan drug act: restoring the mission to rare diseases. Am J Clin Oncol. 2016;39(2):210–213.

 Web of Science ®Google Scholar

Ciliberto G, Mancini R, Paggi MG. Drug repurposing against COVID-19: focus on anticancer agents. Journal of Experimental & Clinical Cancer Research. 2020;39(1):86.

 Web of Science ®Google Scholar

Availability of data and materials

No data was used to write this manuscript.